Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, recently signed a letter of intent with the Nutraceutical Medicine Company Inc. (“PURICA”). PURICA owns and distributes the PURICA product line of full-spectrum, mushroom-derived wellness products. Pure Extracts anticipates the PURICA brand will support PULL’s expansion into the functional mushroom sector. For the past two decades, PURICA has offered natural and whole food products that are backed by science. The company’s Immune 7 formulation has been the Alive Award gold winner for the best immunity product in Canada two years in a row. PURICA has also built a strong reputation for educating consumers about the uses and benefits of medicinal full-spectrum mushrooms, including stress relief, improved sleep, heart health, weight management, endurance, performance, hormonal balance and a host of other conditions. “We are excited to be working with the experts at PURICA on functional mushroom products and novel CBD formulations,” said Pure Extracts CEO Ben Nikolaevsky in the press release. “They have an impressive history of product development, customer retention and an unwavering dedication to high standards.”
To view the full press release, visit https://ibn.fm/vPh1t
About Pure Extracts Technologies Corp.
Pure Extrqacts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. On Sept. 25, 2020, Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act. The company’s stock began trading on the Canadian Securities Exchange (CSE) on Nov. 5, 2020. For more information about the company, please visit www.PureExtractsCorp.com.
NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://ibn.fm/PULL
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire is part of the InvestorBrandNetwork.